Molecular classification of endometrial carcinoma: clinical utility of an NGS panel with targeted detection of 116 cancer-related genes
Lingfeng Chen, Zhijie You, Xunbin Yu, Yijuan Wu, Xin Chen, Jie Lin · 2026
Read Molecular classification of endometrial carcinoma: clinical utility of an NGS panel with targeted detection of 116 cancer-related genes by Lingfeng Chen, Zhijie You, Xunbin Yu, Yijuan Wu, Xin Chen, Jie Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13457160.txt.
Description
Lingfeng Chen and colleagues test whether one gene-sequencing panel can sort endometrial carcinoma into its molecular subtypes as reliably as the standard two-step approach. Molecular subtype now guides prognosis and treatment choices for this cancer of the uterine lining. The 2026 study compares a targeted next-generation sequencing panel covering 116 cancer-related genes against classification built from Sanger sequencing plus immunohistochemistry.
Across 194 classified cases the two routes agreed in 93.8 percent of cases, and agreement rose further once seven disputed POLE mutations were set aside. Sequencing caught 30 POLE mutations where Sanger found 23, missing low-frequency variants. Among 131 tumors the panel also flagged changes in PTEN, PIK3CA, and ARID1A that could point patients toward targeted-therapy trials. The authors conclude that a single sequencing test can match the older workflow while adding sensitivity.
Catalog record
| CREATOR | Lingfeng Chen, Zhijie You, Xunbin Yu, Yijuan Wu, Xin Chen, Jie Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |